Ali Poyan Mehr, MD

Ali Poyan Mehr, MD, is regional director of the Glomerular Disease Program at Kaiser Permanente Northern California.











Most recent by Ali Poyan Mehr, MD

SPONSORED CONTENT
June 28, 2024
1 min watch
Save

VIDEO: No one-size-fits-all for IgA nephropathy

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses how he approaches putting together a treatment plan for IgA nephropathy.

SPONSORED CONTENT
June 28, 2024
5 min watch
Save

VIDEO: Early diagnosis, prognostic markers among biggest unmet needs in IgA nephropathy

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses some of the major unmet needs in the treatment of IgA nephropathy.

SPONSORED CONTENT
June 28, 2024
3 min watch
Save

VIDEO: Risk factors for IgA nephropathy still unclear

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses the major risk factors for IgA nephropathy.

SPONSORED CONTENT
June 28, 2024
1 min watch
Save

VIDEO: Patients with IgA nephropathy should keep watch for proteinuria

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses how IgA nephropathy patients should be aware for even mild proteinuria.

SPONSORED CONTENT
June 28, 2024
4 min watch
Save

VIDEO: New targets under investigation 'act on different targets across the chain of IgA nephropathy'

In this video, Ali Poyan Mehr, MD, Regional Director of the Glomerular Disease Program at Kaiser Permanente Northern Califorina, provides insight into several ongoing studies into future IgA nephropathy treatments.

SPONSORED CONTENT
June 28, 2024
4 min watch
Save

VIDEO: 'Tectonic shifts' occurring in IgA nephropathy treatment landscape

In this video, Ali Poyan Mehr, MD, regional director of the Glomerular Disease Program at Kaiser Permanente Northern California, discusses some of the major shifts in IgA nephropathy treatment and study in recent years.